What Are Embedded Research Partners?
Embedded research partners provide the infrastructure, personnel, systems, and operational support required to conduct clinical trials within existing healthcare practices.
The objective is not simply to place a study inside a physician’s office.
A successful embedded research model connects clinical trial operations with the physicians, patients, workflows, facilities, and care relationships already present within the practice.
Depending on the partnership model, the organization may support:
- Study feasibility
- Site selection
- Research staffing
- Regulatory documentation
- Investigator training
- Patient identification
- Recruitment and retention
- Research technology
- Quality oversight
- Sponsor and CRO communication
- Financial and administrative processes
- Ongoing study management
This structure allows physicians to participate in healthcare research without requiring their practices to build an entire research operation independently.
It also gives sponsors access to community-based patient populations while maintaining centralized operational standards.
Why Sponsors Are Exploring Embedded Research Models
Sponsors face continued pressure to improve recruitment, reduce delays, expand access, and conduct studies in populations that more accurately reflect real-world clinical care.
Traditional site models can struggle when multiple trials compete for the same investigators and patients at the same established research centers.
Activating additional sites does not automatically solve the problem.
A site may appear attractive during feasibility but still lack:
- Access to the target patient population
- Dedicated research personnel
- Appropriate operational infrastructure
- Investigator availability
- Reliable recruitment processes
- Experience with protocol implementation
- Systems for quality and compliance
Embedded research can address some of these limitations by bringing trials into established medical practices and surrounding those practices with centralized research support.
For sponsors, the value of this model depends heavily on the quality of the partner selected. This model aligns with FDA guidance on integrating randomized controlled trials into routine clinical practice, which supports streamlined study procedures and research conducted closer to where patients normally receive care.
1. Access to Established Patient Populations
The first criterion is meaningful access to patients who may be appropriate for the study.
Some organizations emphasize the total number of physicians or locations within their network. However, network size alone does not confirm that a partner can reach patients who meet a specific protocol’s inclusion and exclusion criteria.
Strong embedded research partners should understand the therapeutic areas, patient demographics, referral patterns, diagnosis volumes, and clinical workflows within their affiliated practices.
Sponsors should ask:
- Which patient populations are accessible through the network?
- How are potential participants identified?
- How are feasibility estimates developed?
- What clinical data supports projected enrollment?
- Do participating practices manage the relevant condition?
- Are physicians actively engaged in patient identification?
- How is patient privacy protected during outreach?
Reliable patient access should be based on established care relationships and realistic feasibility, not broad population estimates.
A community practice may offer greater value than a larger research center when it has direct access to a concentrated population that matches the study protocol.
2. Ability to Enable Community Healthcare Sites
A physician’s interest in research does not automatically make a healthcare practice research-ready.
Community practices may need support with staffing, regulatory documentation, technology, training, research workflows, space planning, source documentation, equipment, and investigational product management.
Effective embedded research partners should provide a clear site-enablement process.
This process should evaluate:
- Investigator interest and availability
- Relevant patient population
- Facility capabilities
- Required equipment
- Research staffing needs
- Technology requirements
- Clinical and research workflows
- Regulatory readiness
- Quality risks
- Protocol-specific requirements
The partner should also define which activities are managed locally and which are supported centrally.
Clear accountability is essential.
Physicians and practice teams should understand their responsibilities without becoming overwhelmed by administrative tasks that could interfere with routine patient care.
The goal is to create a research-capable site while allowing the healthcare practice to continue operating effectively.
3. Clinical Trials Integration Into Routine Patient Care
One of the main advantages of embedded research is the ability to introduce clinical trial opportunities within a familiar healthcare environment.
However, successful clinical trials integration requires more than assigning a coordinator to a medical office.
Research activities must fit within the practice’s existing workflows while maintaining appropriate separation between standard care and protocol-required procedures.
Sponsors should evaluate how the partner manages:
- Patient identification during routine visits
- Physician referrals to the research team
- Communication between clinical and research personnel
- Scheduling of research visits
- Access to relevant medical records
- Documentation responsibilities
- Participant follow-up
- Coordination between standard care and study procedures
Poor integration can disrupt the practice, confuse patients, and place additional pressure on clinical staff.
Strong integration allows research in clinical practice to become a structured and accessible option without compromising routine patient care.
The partner should demonstrate that its model supports both clinical operations and research requirements.
4. Centralized Operational Support
Community healthcare practices may have strong physician relationships and access to patients but limited experience with the operational requirements of clinical trials.
Centralized support is therefore a critical capability.
Qualified embedded research partners should provide consistent operational processes across participating sites.
These capabilities may include:
- Protocol feasibility
- Site qualification
- Regulatory document preparation
- Budget and contract coordination
- Research staffing
- Investigator onboarding
- Site training
- Technology implementation
- Recruitment planning
- Participant scheduling
- Sponsor communication
- Performance monitoring
- Issue escalation
- Study closeout support
Centralized oversight gives sponsors and CROs a more consistent point of communication.
It can also reduce variation across community practices by providing common systems, expectations, and performance standards.
Sponsors should assess whether the partner has sufficient internal resources to support the number and complexity of studies it manages.
A partner should not rely entirely on individual practices to solve operational challenges independently.
5. Patient Recruitment and Retention Capabilities
Patient access is valuable only when the organization has effective processes for recruitment and retention.
Sponsors should understand how patients move through the recruitment journey, from initial identification to prescreening, consent, enrollment, and study completion.
Potential embedded research partners should be able to explain:
- How potentially eligible patients are identified
- Who reviews initial eligibility
- How patients are contacted
- How quickly inquiries are addressed
- How study information is explained
- How prescreening is conducted
- How visits are scheduled
- How recruitment performance is monitored
- How participation barriers are addressed
- How retention is supported
Recruitment should not depend exclusively on digital advertising or third-party patient databases.
The embedded model creates an opportunity to engage patients through trusted healthcare relationships, but that advantage must be supported by clear communication and efficient operations.
Patients need to understand:
- Why the study is being conducted
- What participation involves
- How long the study may last
- Which procedures may be required
- How frequently they must visit the site
- Whether compensation or travel support is available
- How their privacy is protected
- That participation is voluntary
Retention should be considered from the beginning of trial implementation.
Convenient locations, familiar healthcare teams, clear expectations, responsive communication, and reliable scheduling can help reduce missed visits and participant withdrawal.
6. Consistent Trial Implementation Across Sites
Conducting studies across multiple community practices can create operational variability.
Each practice may have different staffing structures, appointment systems, patient workflows, facilities, and levels of previous research experience.
Sponsors should prioritize embedded research partners that can standardize essential processes while adapting to the practical needs of each location.
Standardization may include:
- Site onboarding
- Investigator training
- Coordinator responsibilities
- Source documentation
- Participant communication
- Data entry expectations
- Safety reporting
- Protocol deviation management
- Quality checks
- Performance reporting
- Issue escalation
Consistent trial implementation helps sponsors identify risks, compare performance, and reduce unnecessary variation across sites.
The partner should also explain how it handles protocols that require specialized equipment, procedures, staffing, laboratories, imaging, pharmacy support, or external referrals.
A scalable model should be standardized without becoming inflexible.
The strongest partners can maintain operational consistency while adapting responsibly to the needs of individual protocols and community practices.
7. Quality, Compliance, and Study Execution
Patient access and rapid site activation are important, but they cannot replace quality and compliance.
Sponsors should evaluate whether the partner has trained personnel, documented procedures, investigator oversight, and a defined quality management system.
Important areas to assess include:
- Good Clinical Practice training
- Regulatory document management
- Protocol compliance
- Informed consent processes
- Participant safety reporting
- Data quality and completeness
- Investigational product accountability
- Internal quality reviews
- Corrective and preventive actions
- Audit readiness
- Inspection readiness
- Risk identification and escalation
Strong study execution requires both centralized oversight and local accountability.
The partner should be able to monitor site performance, identify operational issues, and intervene before those issues affect enrollment, participant safety, data quality, or study timelines.
Sponsors should also review how performance is communicated.
Clear reporting should provide visibility into enrollment, screening, retention, deviations, data entry, regulatory status, and unresolved risks.
Questions to Ask Embedded Research Partners
Before selecting a partner, sponsors and CROs should ask practical questions about the organization’s operating model.
Key questions include:
- How are community practices identified and qualified?
- What patient populations are accessible?
- How are enrollment projections validated?
- Who provides research coordinators and site personnel?
- How are investigators and practice teams trained?
- How is research integrated into routine patient care?
- Which activities are managed centrally?
- How are sites monitored after activation?
- How are recruitment challenges addressed?
- How is participant retention supported?
- How are quality and compliance maintained?
- How are operational issues escalated?
- How quickly can suitable sites be activated?
- What information is reported to sponsors and CROs?
- How does the organization maintain consistency across locations?
The answers should demonstrate defined systems, realistic patient access, operational accountability, and reliable study execution.
The Value of Research in Clinical Practice
Integrating healthcare research into community practices can expand access to clinical trials for patients who may never visit a major academic institution or dedicated research center.
It can also allow physicians to discuss research opportunities as part of the broader care options available to eligible patients.
When supported by the right infrastructure, research in clinical practice can:
- Expand access to study opportunities
- Strengthen physician engagement
- Improve diverse patient recruitment
- Reduce geographic barriers
- Support participant retention
- Connect healthcare innovation with local communities
- Create new pathways for trial implementation
The model works best when research operations support the healthcare practice rather than disrupt it.
Physicians should remain focused on patient care while the embedded research organization provides the systems, staff, and operational support required for trial execution.
Choosing the Right Embedded Research Partner
Sponsors should not choose embedded research partners based only on network size or the number of affiliated physicians.
The strongest partner combines:
- Verified patient access
- Community site enablement
- Clinical trials integration
- Centralized operational support
- Recruitment and retention capabilities
- Consistent trial implementation
- Quality oversight
- Reliable study execution
A well-designed embedded research strategy can help sponsors reach patients within trusted healthcare settings while giving community practices the infrastructure required to conduct trials responsibly.
The right partner should function as an extension of the sponsor and CRO study team, providing operational consistency without losing the local relationships that make community-based research valuable.
Bring Clinical Trials Into Community Care
FOMAT Medical Research helps sponsors and CROs integrate clinical trials into established healthcare practices through centralized site enablement, patient access, operational support, and study execution.
By connecting research with routine community care, FOMAT helps create more accessible clinical trial opportunities for patients while supporting the operational and quality expectations of pharmaceutical sponsors and CROs.